Company Research Report: Atria Ventures
Company Overview
Name
Atria Ventures
Mission
No information is available
Founding Information
- Founded by: No information is available
- Year of Foundation: No information is available
Key People
No information is available
Headquarters
No information is available
Number of Employees
No information is available
Revenue
No information is available
Core Competency
Atria Ventures partners with companies that drive a new era of AI-driven bioacceleration. They focus on building the engineering, data science, machine learning, automation, software tooling, and computation needed for groundbreaking advancements in science and medicine.
Products and Services
Atria Ventures collaborates with several companies, whose offerings are briefly described below:
1. Abridge
- Description: Enterprise generative AI for clinical conversations.
- Key Features: No information is available.
2. Axiom
- Description: Eliminates molecular toxicity by replacing experiments with AI.
- Key Features: No information is available.
3. Evolv
- Description: Develops natural products aimed at pharmaceutical grade efficacy.
- Key Features: No information is available.
4. HoX
- Description: Provides vertically integrated genomics computing.
- Key Features: No information is available.
5. Lighten
- Description: Focuses on unstructured data abstraction for modern medicine.
- Key Features: No information is available.
6. Molecule
- Description: Offers a decentralized protocol for early-stage biology discovery and funding.
- Key Features: No information is available.
7. Peer
- Description: Focused on rewriting regulated biopharma workflows.
- Key Features: No information is available.
8. Photon
- Description: Provides modern patient-first pharmacy infrastructure.
- Key Features: No information is available.
9. ReSync
- Description: Serves as a single source of truth for scientific workflows.
- Key Features: No information is available.
10. ReachRX
- Description: A data science platform for specialty pharma.
- Key Features: No information is available.
11. Sensible Bio
- Description: Specializes in in vivo mRNA biomanufacturing.
- Key Features: No information is available.
12. Sleuth
- Description: Provides agentic business intelligence for biopharma.
- Key Features: No information is available.
13. Specie Bio
- Description: Offers biospecimen data exchange for clinical research.
- Key Features: No information is available.
14. Tandem
- Description: Provides automated market access for specialty pharma patients and clinicians.
- Key Features: No information is available.
15. Trially
- Description: Deals with integrated clinical trial automation for sponsors and sites.
- Key Features: No information is available.
16. Velocity Bio
- Description: Focuses on targeting underdrugged enzymatic diseases.
- Key Features: No information is available.
Note: Some are extended portfolio companies and are denoted with an asterisk ().*
Recent Developments
New Developments in the Company
No information is available
New Products Launched
No information is available
New Features Added to Existing Products
No information is available
New Partnerships
No information is available
This professional report provides an overview based solely on the available data for Atria Ventures.
